Positive and Negative Effects of Cannabis and Cannabinoids on Health.

@article{Cohen2019PositiveAN,
  title={Positive and Negative Effects of Cannabis and Cannabinoids on Health.},
  author={Koby Cohen and Avraham Weizman and Alyse Weinstein},
  journal={Clinical pharmacology and therapeutics},
  year={2019},
  volume={105 5},
  pages={
          1139-1147
        }
}
Cannabis is the most popular illicit drug in the Western world. Repeated cannabis use has been associated with short- and long-term side effects, including respiratory and cardiovascular disorders, cognitive alterations, psychosis, schizophrenia, and mood disorders. However, casual relations between cannabis use and these adverse effects are missing. On the other hand, recent research proposed promising therapeutic potential of cannabinoid-based drugs for a wide range of medical conditions… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 131 REFERENCES

Assessing the public health impacts of legalizing recreational cannabis use in the USA.

  • Clinical pharmacology and therapeutics
  • 2015
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Safety and Toxicology of Cannabinoids

VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

a case control study

Di Forti, M. et al. Proportion of patients in south London with cannabis
  • Lancet Psychiatry 2, 233–238
  • 2015
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

an overview

R. Tanasescu, Constantinescu, C. S. Cannabinoids, the immune system
  • Immunobiology 215, 588–597
  • 2010
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

an fMRI study

S. A. Gruber, J. Rogowska, Yurgelun-Todd, D. A. Altered affective response in marijuana smokers
  • Drug Alcohol Depend. 105, 139–153
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Δ9tetrahydrocannabinol, cannabidiol and Δ9 tetrahydrocannabivarin

Pertwee, R. G. The diverse CB1, CB2 receptor pharmacology of three plant cannabinoids
  • Br. J. Pharmacol. 153, 199–215
  • 2008
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

a multicenter randomized controlled trial

McGuire, P. et al. Cannabidiol as an adjunctive therapy in schizophrenia
  • Am. J. Psychiatry 175, 225–231
  • 2017
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL